Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,394 | 1,835 | 1,435 | 1,316 | 678 |
| Operating Income | -2,394 | -1,835 | -1,435 | -1,316 | -678 |
| Other Income | 10 | -65 | 24 | 189 | 21 |
| Pre-tax Income | -2,384 | -1,899 | -1,411 | -1,127 | -657 |
| Net Income Continuous | -2,384 | -1,899 | -1,411 | -1,127 | -657 |
| Net Income | $-2,384 | $-1,899 | $-1,411 | $-1,127 | $-657 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.03 | -0.03 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.03 | -0.03 | -0.01 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.03 | -0.03 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.03 | -0.03 | -0.01 |
| EBITDA(a) | $-2,394 | $-1,835 | $-1,435 | $-1,316 | $-678 |